Frankfurt-am-Main, Germany

Manfred Wieduwilt


Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1991-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Manfred Wieduwilt: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Wieduwilt is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibacterial compounds. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Wieduwilt's latest patents include a process for the preparation of crystalline TACA. This innovative method involves the presence of a base and subsequent precipitation by adding a TACA solution to a partial amount of an acid, which may also contain a precipitation auxiliary. The process is completed by further addition of acid or TACA solution and acid. Another significant patent focuses on cephalosporin derivatives, which are anti-bacterially active compounds. This patent details pharmaceutical preparations containing such compounds, methods of making them, and their application in combating bacterial infections.

Career Highlights

Manfred Wieduwilt has had a distinguished career at Hoechst Aktiengesellschaft, where he has been instrumental in advancing pharmaceutical research. His expertise in chemical processes has led to the development of innovative solutions that address critical health challenges.

Collaborations

Throughout his career, Wieduwilt has collaborated with esteemed colleagues such as Rudolf Lattrell and Walter Durckheimer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Manfred Wieduwilt is a prominent inventor whose work in pharmaceutical chemistry has led to valuable advancements in antibacterial treatments. His contributions continue to influence the field and improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…